COVID-19 TESTING

Quality Laboratory Service is proud to offer the most advanced FDA-approved COVID-19 testing solutions on the market. We are performing high sensitivity/high specificity SARS-CoV-2 antibody testing, COVID-19 diagnostic testing, and we have created 3 comprehensive panels designed to give physicians a complete picture of this patients' health during these difficult times. In particular, our Quarantine Wellness Panel is unique to QLS, and offers doctors a snapshot of their patients' health, including the SARS-CoV-2 antibody test. Click on the following links to learn more about these testing options!

Should you have any questions, please do not hesitate to contact us at 718-646-5100.

Physician Referral is required for all insurance claims.

$50 for self-pay patients. Please call us for discount eligibility.

SARS-CoV-2 Quarantine Wellness Panel

HEAVY METALS

What are Heavy Metals?

Heavy metals, like arsenic, lead, mercury, and others,are all around us. They’re in the ground we walk on, in the water we drink, and in the products we use every day. But high levels of most heavy metals are potentially toxic.QLS offers a comprehensive heavy metals panel in-house that helps physicians screen patients for a variety of medical conditions. Click on the following link to learn more about the testing options available!

Should you have any questions, please do not hesitate to contact us at 718-646-5100.

Learn more

4902 Tobramycin

Components

	NAME	METHOD	REFERENCE RANGE	UNITS
	Tobramycin	EMIT	REFERENCE RANGE for Tobramycin: Peak Therapeutic Level: 5.0 - 10.0 ug/mL Trough Level: 1.0 - 2.0 ug/mL	ug/mL

Specimen Requirements

	TYPE	VOLUME	TEMPERATURE	INSTRUCTIONS
PRIMARY
1	Serum	1 (0.2) mL	Refrigerated - 7 Day(s), Frozen - 2 Month(s)	Red top serum separator tubes are not acceptable.

Clinical utility

Tobramycin is one of the aminoglycoside class of bactericidal drugs, also including streptomycin, neomycin, netilmycin, sisomycin, gentamycin, kanamycine, and amikacin. Due to toxic effects associated with aminoglycosides manifest as delayed-onset vestibular and cochlear sensory cell destruction and acute renal tubular necrosis, the goal of monitoring is to maintain therapeutic plasma concentration at minimum risk to patients.

Collection Instruction

For peak concentration, collect specimen at the end of the
infusion or 30-90 minutes after IM administration. For
trough concentration, collect specimen within 30 minutes
before adminstration of next dose. Serum separator tubes
are not acceptable.

Reported: Same day

CPT Code: 80200